Optimization of the potency, specificity and survival properties of engineered regulatory T cells to treat inflammatory liver diseases

Project: Research

Project Details

StatusActive
Effective start/end date1/12/202130/11/2024

Collaborative partners

Funding

  • Rosetrees Trust: £198,505.48